Exciting Breakthrough in CAR-T Cell Therapy Offers New Hope for Solid Tumor Treatment. In a groundbreaking study that could revolutionize cancer treatment, researchers have unveiled a new CAR-T cell...
In an exciting development in the field of cancer immunotherapy, researchers have engineered a new dual-target CAR T-cell therapy that simultaneously targets two key antigens, CD19 and CD20, in...
Unlock the Potential of Advanced Therapies: Join Our Crash Course! Are you ready to dive into the world of Advanced Therapeutic Medicinal Products (ATMPs)? Our two-day *Crash Course for...
Image by Erin_Hinterland/pixabay A groundbreaking study has delved into the potential interactions between cannabidiol (CBD) and CD19-chimeric antigen receptor (CAR) T cell therapy, a promising approach in cancer immunotherapy....
2023 Frontiers in Basic Immunology The Center for Cancer Research at the National Cancer Institute is hosting a two-day international symposium on September 27-28, 2023 entitled 2023 Frontiers in...
Thailand Hub of Talent for Cancer Immunotherapy International Conference: Portal to Global Collaboration for Next Generation Cell and Gene Therapy Development Date: 16-17th November 2023Venue: Bhumisiri Mangklanusorn Building, Faculty...
Image by Herney/pixabay In a notable advancement in cell engineering research, scientists have developed the first ligand-based, piggyBac-transfected anti-EGFR CAR-T cells, targeting non-small cell lung cancer (NSCLC). NSCLC often...
TTCI Webinar Series “Immunology in Single-cell Genomics Era” On behalf of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI), we would like to inform you of the link...
TTCI Webinar Series “Immunometabolism : From Metabolomics to Respiration” On behalf of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI), we would like to inform you of the...
TTCI Webinar Series “Immunometabolomics” August 10, 2023 On behalf of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI), we would like to inform you of the link for...